These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17714375)

  • 1. ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD.
    Epstein JN; Casey BJ; Tonev ST; Davidson MC; Reiss AL; Garrett A; Hinshaw SP; Greenhill LL; Glover G; Shafritz KM; Vitolo A; Kotler LA; Jarrett MA; Spicer J
    J Child Psychol Psychiatry; 2007 Sep; 48(9):899-913. PubMed ID: 17714375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced activation and inter-regional functional connectivity of fronto-striatal networks in adults with childhood Attention-Deficit Hyperactivity Disorder (ADHD) and persisting symptoms during tasks of motor inhibition and cognitive switching.
    Cubillo A; Halari R; Ecker C; Giampietro V; Taylor E; Rubia K
    J Psychiatr Res; 2010 Jul; 44(10):629-39. PubMed ID: 20060129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.
    Shafritz KM; Marchione KE; Gore JC; Shaywitz SE; Shaywitz BA
    Am J Psychiatry; 2004 Nov; 161(11):1990-7. PubMed ID: 15514398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task-specific hypoactivation in prefrontal and temporoparietal brain regions during motor inhibition and task switching in medication-naive children and adolescents with attention deficit hyperactivity disorder.
    Smith AB; Taylor E; Brammer M; Toone B; Rubia K
    Am J Psychiatry; 2006 Jun; 163(6):1044-51. PubMed ID: 16741205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
    Yoo JH; Kim D; Choi J; Jeong B
    Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.
    Czerniak SM; Sikoglu EM; King JA; Kennedy DN; Mick E; Frazier J; Moore CM
    Harv Rev Psychiatry; 2013; 21(3):151-62. PubMed ID: 23660970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].
    Huber M; Kirchler E; Niederhofer H; Gruber L
    Fortschr Neurol Psychiatr; 2007 May; 75(5):275-84. PubMed ID: 17443438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention.
    Cubillo A; Halari R; Smith A; Taylor E; Rubia K
    Cortex; 2012 Feb; 48(2):194-215. PubMed ID: 21575934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain abnormalities in attention-deficit hyperactivity disorder: a review.
    Rubia K; Alegría AA; Brinson H
    Rev Neurol; 2014 Feb; 58 Suppl 1():S3-16. PubMed ID: 25252664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.